{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:35:45Z","timestamp":1793907345440,"version":"4.8.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The triglyceride-glucose (TyG) index is a recognized surrogate marker of insulin resistance but lacks integration of high-density lipoprotein cholesterol (HDL-C) and adiposity measures, which are pivotal in the pathogenesis of diabetic kidney disease (DKD). The novel triglyceride-high-density lipoprotein-glucose-body (TyHGB) index, combining TG\/HDL-C ratio, fasting blood glucose (FBG), and body mass index (BMI), may offer a more comprehensive metabolic profile. This study aimed to evaluate the associative value of TyHGB for DKD in type 2 diabetes mellitus (T2DM) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cross-sectional analysis of 1,382 adults with T2DM was conducted. We employed multivariable logistic regression, restricted cubic spline (RCS) analysis, and subgroup analyses to assess the independent and non-linear association of the TyHGB index with DKD. Receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to evaluate and compare its associative performance against the TyG index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the participants, 286 (20.7%) were diagnosed with DKD. After full adjustment for demographic, clinical, and biochemical confounders, TyHGB was independently associated with DKD (OR\u00a0=\u00a01.11, 95%CI:1.05-1.17, p&amp;lt;0.001). RCS analysis revealed a significant non-linear relationship, with a sharp increase in DKD risk beyond a TyHGB threshold of 8.74. The TyHGB index demonstrated superior discriminative ability (AUC\u00a0=\u00a00.775, 95% CI: 0.747-0.803) compared to the TyG index (AUC\u00a0=\u00a00.644, p&amp;lt;0.001). Incorporating TyHGB into a baseline clinical model significantly improved risk association (AUC increased from 0.715 to 0.788, p&amp;lt;0.001) and provided substantial reclassification improvement (NRI\u00a0=\u00a00.647, IDI\u00a0=\u00a00.067).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The TyHGB index exhibits a robust, independent, and non-linear association with DKD risk in T2DM patients and outperforms the established TyG index. As a readily accessible composite metric, it holds significant promise as a superior tool for early identification and risk stratification of DKD in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1749826","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:40:03Z","timestamp":1768196403000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The triglyceride-high-density lipoprotein-glucose-body index: a superior novel biomarker for diabetic kidney disease in type 2 diabetes"],"prefix":"10.3389","volume":"16","author":[{"given":"Jian","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingsong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mcna.2023.03.004","article-title":"Diabetic kidney disease: an update","volume":"107","author":"Gupta","year":"2023","journal-title":"Med Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06108-5","article-title":"Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank","volume":"67","author":"Jin","year":"2024","journal-title":"Diabetologia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12933-024-02371-3","article-title":"Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial","volume":"23","author":"Minutolo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1531811","article-title":"Global, regional, and national burden of chronic kidney disease due to diabetes mellitus type 2 from 1990 to 2021, with projections to 2036: a systematic analysis for the Global Burden of Disease Study 2021","volume":"12","author":"Hu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4959-1","article-title":"New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism","volume":"62","author":"Eid","year":"2019","journal-title":"Diabetologia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1602594","article-title":"Immune inflammation and metabolic interactions in the pathogenesis of diabetic nephropathy","volume":"16","author":"Hou","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2337\/db20211-2","article-title":"Pathogenesis of diabetic nephropathy","volume":"2021","author":"Agarwal","year":"2021","journal-title":"ADA Clin Compendia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2024.0132","article-title":"Assessment of cardiometabolic risk factors and insulin sensitivity by hyperinsulinemic-euglycemic clamp in resistance to thyroid hormone \u03b2 Syndrome","volume":"34","author":"Domingues-Hajj","year":"2024","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12902-025-01887-3","article-title":"Triglyceride-glucose index: a potent predictor of metabolic risk factors and eating behavior patterns among obese individuals","volume":"25","author":"El-Sehrawy","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.1038\/s41598-024-84917-9","article-title":"Association between TyG related parameters and metabolic dysfunction associated fatty liver disease among nondiabetic individuals","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12933-025-02902-6","article-title":"Evaluative performance of TyG-ABSI versus traditional indices in relation to cardiovascular disease and mortality: evidence from the U.S. NHANES","volume":"24","author":"Zheng","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1358358","article-title":"The causal relationship between 5 serum lipid parameters and diabetic nephropathy: a Mendelian randomization study","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2420841","article-title":"Lipid metabolism disorders and albuminuria risk: insights from National Health and Nutrition Examination Survey 2001\u20132018 and Mendelian randomization analyses","volume":"46","author":"Wang","year":"2024","journal-title":"Ren Fail"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1897","article-title":"Establishment and validation of a risk prediction model for early diabetic kidney disease based on a systematic review and meta-analysis of 20 cohorts","volume":"43","author":"Jiang","year":"2020","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12967-025-06166-2","article-title":"Association between the new TyG indicator-TyHGB and gestational diabetes mellitus: results from the case-control and prospective cohort studies","volume":"23","author":"Xu","year":"2025","journal-title":"J Transl Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12944-025-02742-z","article-title":"Evaluation of a new TyG indicator, TyHGB, in predicting non-alcoholic fatty liver disease: evidence from two independent populations","volume":"24","author":"Zhao","year":"2025","journal-title":"Lipids Health Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/ijgo.13905","article-title":"HOMA-IR as a risk factor of gestational diabetes mellitus and a novel simple surrogate index in early pregnancy","volume":"157","author":"Song","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the american diabetes association (ADA) and the european association for the study of diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1671-7368.2017.10.002","article-title":"Diagnosis and differential diagnosis of diabetic kidney disease","volume":"16","author":"Guo","year":"2017","journal-title":"BMJ-British Med J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0329","article-title":"Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease","volume":"46","author":"Jung","year":"2022","journal-title":"Diabetes Metab J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-021-01936-3","article-title":"Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study","volume":"19","author":"Penno","year":"2021","journal-title":"BMC Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S318255","article-title":"Relationship between the tyG index and diabetic kidney disease in patients with type-2 diabetes mellitus","volume":"14","author":"Lv","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13371","article-title":"Association between the triglyceride-glucose index and diabetic nephropathy in patients with type 2 diabetes: A cross-sectional study","volume":"12","author":"Liu","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1328601","article-title":"Association between the triglyceride glucose index, triglyceride-glucose body mass index and diabetic kidney disease in adults with newly diagnosed type 2 diabetes","volume":"11","author":"Jiang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0312374","DOI":"10.1371\/journal.pone.0312374","article-title":"Associations of the TyG index with albuminuria and chronic kidney disease in patients with type 2 diabetes","volume":"19","author":"Li","year":"2024","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1246","article-title":"AMD-Annals Study Group. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative","volume":"39","author":"Russo","year":"2016","journal-title":"Diabetes Care"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-01080","article-title":"HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study","volume":"104","author":"Lee","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00179.2022","article-title":"Obesity and chronic kidney disease","volume":"324","author":"Jiang","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030495","article-title":"The U-shape relationship between triglyceride-glucose index and the risk of diabetic retinopathy among the US population","volume":"13","author":"Zhou","year":"2023","journal-title":"J Pers Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/jch.14913.121.16498","article-title":"Association Between Triglyceride Glucose Index and Chronic Kidney Disease in Normal-Weight Chinese Adults With Hypertension","volume":"26","author":"Yu","year":"2024","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1559026","article-title":"An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease","volume":"16","author":"Feng","year":"2025","journal-title":"Front Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S538554","article-title":"Hypertension and BMI as mediators of type 2 diabetes-induced CKD: insights from an integrative multi-database study","volume":"18","author":"Wang","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","article-title":"Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals","volume":"11","author":"Er","year":"2016","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","article-title":"Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0-3: a nationwide prospective cohort study","volume":"23","author":"Li","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1749826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:40:05Z","timestamp":1768196405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1749826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":37,"alternative-id":["10.3389\/fendo.2025.1749826"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1749826","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1749826"}}